In summary, the present review reported irisin may represent a novel PCOS biomarker and might directly contribute to the etiology of PCOS or indirectly affect the development of disordered metabolism (such as obesity, hyperandrogenism, impaired glucose tolerance, and insulin resistance) in PCOS [58]. Here, FNDC5 is linked to polycystic ovary syndrome.